Breakthrough Diabetes Drug

Francisco sheds light on the journey of teplizumab, a potential game-changer in diabetes treatment. With FDA review looming, the drug aims to protect beta cells and intercept autoimmune attacks. Emphasizing the importance of early screening, initiatives like T1 Detect offer hope for preventing disease in at-risk individuals.